Internet Pharmacy Site Disclosure

Internet Pharmacy Site Disclosure

Pursuant to section 311(c) of the Controlled Substances Act (21 U.S.C. 831(c)), VALISURERX, LLC, as an online pharmacy, acknowledges and agrees to post the following Internet Pharmacy Site Disclosure information in a visible and clear manner on the homepage of each Internet site you operate, or on a page directly linked thereto in which the hyperlink is also visible and clear on the homepage:

VALISURERX, LLC

5 SCIENCE PARK, 1st FLOOR

NEW HAVEN, CT 06511

 

Certification that the pharmacy is registered to deliver, distribute, or dispense by means of the Internet, controlled substances is provided by the DEA via certificate number FV7431137.

Issue Date : 03/27/2018
Expires : 05/31/2021
Schedules : 2,2N,3,3N,4,5
Telephone Number : 1-833-497-7370
Fax Number : 1-203-497-7371
Email Address : info@valisure.com
States of Licensure : 11 states (AL, AZ, CO, CT, FL, NV, NY, OH, RI, WA, WY)
Currently pending : 10 states (DE, GA, HI, ID, IL, MT, NH, ND, PA, SC)
Pharmacist In Charge : Paul Barry R.Ph.
Degree: : Bachelor of Science in Pharmacy
States of Licensure : 1 state
Connecticut license – PCT.0006910
NPI # 1740771021

VALISURERX, LLC has no relationships with any practitioner to provide medical evaluations or prescriptions for controlled substances through referrals from any entity, owner or operator of any website, or any employee or agent thereof.

 

VALIRURERX, LLC, as an online pharmacy is obligated to comply fully with the Controlled Substances Act and DEA regulations. As part of this obligation, VALISURERX, LLC has obtained a modified DEA registration authorizing it to operate as an online pharmacy. In addition, this mail-order retail pharmacy will only dispense a controlled substance to a person who has a valid prescription issued for a legitimate medical purpose based upon a medical relationship with a prescribing practitioner. This includes at least one prior in-person medical evaluation in accordance with section 309 of the Controlled Substances Act (21 U.S.C. 829) or a medical evaluation via telemedicine in accordance with section 102(54) of the Controlled Substance Act (21 U.S.C 802(54)).”

Pursuant to section 311(d)(2)(A) of the Controlled Substances Act (21 U.S.C. 831(d)(2)(A)), VALISURERX, LLC certifies that this Internet Pharmacy Site Disclosure information disclosed on our website, under penalty of perjury, is true and accurate.

In accordance with the Controlled Substances Act and the DEA regulations, VALISURERX, LLC has made the notifications to the DEA Administrator required by 21 U.S.C. 831 and 21 CFR 1304.40.

If you have any questions regarding this policy by VALISURERX, LLC, please feel free to contact us by phone at 877-780-3368 or via email at info@valisure.com.